In this work, we designed and built a continuous crystallisation oscillatory flow platform. The lysozyme crystallisation behaviours were investigated at concentrations from 30 to 100 mg/mL, 
Introduction
Crystallisation of protein has presented the potential to be developed as an efficient approach for protein purification (McPherson, 2004; Shah et al., 2012) , compared to traditionally used chromatographic methods. Typical downstream purification costs can be up to 80% of the manufacturing cost (Zang et al., 2011) . Continuous manufacturing connecting reaction, crystallisation and formulation has been documented to improve the efficiency of manufacturing (Chew et al., 2004; Ni et al., 2004) . The steady-state operation of a continuous crystallisation stabilizes variability in the product, reduce capital costs, and improve control over the CSD of the API (Baxendale et al., 2015) . Many research on continuous crystallizers have been investigated in mixed-suspension, mixed-product removal (MSMPR) crystallizer (Su et al., 2015; Yang et al., 2017) , i.e. continuous stirred tank reactors (CSTRs) (Lai et al., 2015) , plug flow reactor (PFR) (Neugebauer and Khinast, 2015) , continuous (baffled) oscillatory flow reactor/crystalliser (OBR)/(COFC) (Chew et al., 2004; Jian and Ni, 2005; Yang et al., 2016) .
Much efforts in continuous crystallisation have focused on small organic pharmaceuticals (Baxendale et al., 2015; McGlone et al., 2015) . However, knowledge of oscillatory flow crystallisation, like mixing condition (Chew et al., 2004; Yang et al., 2016) , nucleation (Yang et al., 2016) , growth (Brown and Ni, 2011) , process control on small organic pharmaceutical molecules can also help to develop and design protein continuous crystallisation process. However, the differences between crystallisation of proteins with small organic molecules are obvious. Crystallisation of protein is still very difficult primarily due to the complex structures of the proteins (Jacobsen et al., 1998) . For instance, lysozyme, a small and simple protein, consists of 129 amino acids involving hundreds of chemical bonds and thousands of degrees of freedom (Malkin et al., 1996) . Moreover, due to the impurity of the proteins in solution nucleation and crystallisation from fermentation broths are rarely successful. In addition, the crystallisation of protein is also influenced by pH (Chen et al., 2017) , iron strength (McPherson, 2004) , concentration of PEG (McPherson, 1976) , magnetic fields (Hou and Chang, 2008) and etc.
By high-throughput screening or other micro scale technologies, suitable conditions for crystallisation for many proteins, like lipase, thaumatin, catalase, ferritin (Hebel et al., 2013; Shah et al., 2012) , have been determined. However, there are only limited literatures focused on the continuous crystallisation of proteins, for example insulin crystallisation in oscillatory flow glass capillaries (Parambil et al., 2011) and lysozyme crystallisation in meso-oscillatory flow reactor (Castro et al., 2016) and plug flow crystallizer (Neugebauer and Khinast, 2015) .
There is no continuous oscillatory flow crystallisation research on any protein, neither comparing, design and developing platform of continuous oscillatory flow crystallisation reported. This work focuses on the crystallisation of lysozyme, a model protein, in several platforms we designed, scaling up from hundreds of μL to hundreds of times larger scale. The thermodynamics and kinetics of lysozyme were investigated at concentrations from 50 to 130 mg/mL, with oscillatory conditions of amplitude ( 0 ) from 5 to 25 mm and frequency ( ) from 0.05 to 0.25 Hz. The different platforms were compared and the optimizations from batch to continuously protein crystallisation were discussed.
Experimental
Lysozyme from chicken egg white (purity ≥90 %, ≥40,000 units/mg protein), sodium acetate (purity > 99%), sodium chloride (purity > 99.5%), and glacial acetic acid (purity > 99.5 %) were purchased from Sigma and used without further purification. Distilled water was used. 
Results
The velocities of solution with oscillatory during 20 s in BOFC were shown in Figure 2 . In each cycle, the solution in crystallizer was infused to peak value, during which stage the velocity is 4 0 , i.e. 12 mm/s for − 0 at 0.15 Hz -20 mm and 6 mm/s for both 0.15 Hz -10 mm and 0.1 Hz -15 mm. In the next stage, the solution was withdrawn to the max negative value, during which stage the velocity is −4 0 . The change of the direction was dependent on the frequency, the direction changed 6 times (3 cycles) and 4 times (2 cycles) for 0.15 Hz and 0.1 Hz, respectively. It is noted that the velocity of the solution generated by syringe pump is different with that generated by piston pumps, which continuously changes all the time based on a sine function equation (Yang et al., 2016) . In the literatures of lysozyme crystallization, buffer as sodium acetate, pH at around 4.7, and precipitant as sodium chloride (Castro et al., 2016; Durbin and Feher, 1986; Liu et al., 2010; Roberts et al., 2010) were established and is also used in this work. The concentrations of the initial lysozyme solution, 50 -130 mg/mL were investigated in BOFC. Crystallisation solutions with concentrations >100 mg/mL lysozyme solution in BOFC all nucleated within 30 min, while nucleation of the crystallisation solution with 50 mg/mL lysozyme solution occurred at ~60 min. Figure 3 shows the solution concentration reduced to a relative low level after 200 min in almost all experimental conditions. For crystallisation time less than 100 min, the crystallisation solutions with higher initial lysozyme concentrations had higher concentrations than those solutions with the lower initial lysozyme concentrations, while the order was altered after 100 min. The protein crystallisation is different with normal small organic molecules, which the growth of the protein crystal growth is relative slow (Durbin and Feher, 1986) . There are three stages of the changing concentration: (A) induction period (before nucleation), at which stage the decrease of concentration is very low, (B) fast concentration dropping period, i.e.
nucleation (homogeneous and secondary) and fast crystal growth at high supersaturation level, (C) slow concentration decrease period, i.e. crystal growth at low supersaturation level. The decrease rate, , of the concentration during the crystallisation is estimated by successive two samples:
Where n is the sample number, is the respective sampling time, and is the respective concentration determined. Correspondingly, the increased and decreased during the crystallisation process shown in Figure 4 . The crystallisation solution with 130 and 110 mg/mL lysozyme solution had the fastest rate of concentration dropping range ( ), ~ 0.7 and ~ 0.6 mg/mL/min, respectively. Comparing with many cases of small organic crystallisation (Mullin, 2001; Yang and Rasmuson, 2012 ) with a sharp fall of the concentration after nucleation, the concentrations decreased (B-stage) in lysozyme crystallisation at relatively slow rates after nucleation (Neugebauer and Khinast, 2015) , due to high packing energy, low attachment frequency and slow kinetics during the crystal growth (Derewenda and Vekilov, 2006) . The Some larger crystals were obtained from the lysozyme solutions of high concentration compared with those obtained from lower concentration solutions, as shown in Figure 3 .
Because, at this moderate oscillatory condition, the higher concentration induced shorter nucleation time and longer growth time to gain some bigger particles. It is noticed that there were plenty of very fine particles exciting at the same time, due to the higher supersaturation and faster nucleation rate. At more intense oscillation, there were more fine particles without many bigger crystals, due to a higher homogeneous nucleation rate generating larger number of crystals at the B-stage of crystallisation process and the high breakage rate due to the high shear rate (Yang et al., 2018) . Figure 6 , while nucleated at only less than 50 min with 0 at 0.5 Hz (Yang et al., 2018) . There was not obvious difference between the nucleation and concentration at the range of low frequencies, and the nucleation was much faster when the frequency increased to 0.5 Hz. The crystals looked similar in these experiments performed at low frequency range, 0.05 -0.25 Hz. Figure 5 and Figure 6 show an overall trend that the nucleation time increased and the decreased with the decrease in shear rate, i.e. lower frequency or amplitude, i.e. the mixing was not efficient. Whilst only a limited number of experiments for reproducibility is conducted, the observed effects of higher shear rate and higher supersaturation on the nucleation and crystallisation of lysozyme are not due to experimental errors. The results are consistent with the literature that the faster diffusion, resulted by faster mixing, leaded to faster crystal growth and therefore the is higher (Adachi et al., 2002; Parambil et al., 2011) . The difference of the nucleation time was not obvious at very low shear rate range 0.05 -0.15 Hz in Figure 6 . This non uniform mixing could lead to a lower homogeneous nucleation rate or secondary nucleation rate, which is in consistence with the literatures (Ploß and Mersmann, 1989; Yang et al., 2016) . To achieve a shorter equilibrium time, a higher yield (lower final concentration of the crystallisation solution), and a better suspension of the crystals in the crystallisation solution, higher shear rate (i.e. higher frequency of the oscillatory conditions) can be applied (Yang et al., 2018) . In experiments with oscillatory condition at 20 mm -0.45 Hz, the concentrations of crystallisation solutions are lower than that with oscillatory condition at 20 mm -0.15 Hz as expected due to the higher frequency and higher shear rate. Figure 7 shows the consistence 11 between the crystals obtained at 200 min and 300 min, and most of the crystals had good crystalline shape, but there was an extent of agglomerations. The yield estimated from the decrease of the lysozyme concentration was about 50 %, which can be improved by further decrease the temperature or increase the residence time. 
Discussion
In industrial downstream manufacturing, batch crystallisation is commonly used. However, continuous manufacturing including continuous crystallisation (Chew et al., 2004; Ni et al., 2004 ) draw more and more attentions from both industrials and academics Brown and Ni, 2011; Chew et al., 2004; Yang et al., 2016) . Based on the principle of batch crystallizer, the mixed suspension mixed product removal crystallizer (MSMPR) is designed by connecting parallel batch crystalliser (Katoh and Katoh, 2000; Kwon et al., 2014) . With this platform, the materials can be removed and added at same time, but it is very hard to control residence time. To better control the residence time, a semi-continuous crystallisation process can be operated by three successive steps: filling the material in, crystallization and residency, and removing the product. Continuous stirred tank reactor (CSTR) or multi-stage MSMPR (Alvarez et al., 2011; McGlone et al., 2015) had been introduced in crystallisation of small organic molecules which can achieve a better plug flow with increase of the stages or parallel reactors. These designs are suitable for systems that require longer residence times, but its strong agitation and nonuniform temperature profile may cause problems for particle size and polymorphism control as reported in crystallization of small organic molecules (Yang et al., 2017 ).
In our previous work and this work, we have tried to develop a new generation of oscillatory flow crystalliser. Previously, we designed glass capillary circulating flow crystalliser (Roberts et al., 2010) . This is a simple platform by connecting the glass capillary and a circulating pump, and crystals continuously grew in the circulating flow, by an enhanced mass transferring as well as cooling and heating cycles. Recirculating the protein solution in this platform for 40 h increases the crystal yield to 80 % of the total protein, and it offered promise for growing large protein crystals for use in structure determinations and for the mass preparation of protein therapeutics (Roberts et al., 2010) . But the very long residence time and low capacity inside the crystallizer not met the efficient requirement of scaling up. To have better mixing condition, in this work we designed continuous oscillatory flow (tube) crystallizer (Figure 1 ). It is developed based on our previous platform, we used plastic/polymer tubing instead of glass capillary. This brings us the conveniences for changing the materials of the tubing, adjusting the diameter of the tubing, adding blending curves and etc. Many options of materials can be used in design the crystallizer like PTFE, silicon, Nylon, PVC and etc, shown in supporting information. The different bending curves can be applied to achieve higher shear rate. The tube shape can be adjusted easily, dependent on the space requirement and the capacity of the crystallizer. investigations, and the jacket of the PTFE tubing is not easily practicable. A similar but larger scale meso oscillatory flow crystalliser (Castro et al., 2016) , with baffles in glass capillaries and the jacket outside, was reported. This is also a small version of the oscillatory baffle flow crystallizer for small organic compounds reported in literature (Jian and Ni, 2005; Yang et al., 2016) . In large scales, tens of mL to hundreds of mL, it is relative easy to control baffles in the glass tubes. However, making baffles in glass capillary is very difficult, i.e. the baffle shape and size is very hard to uniformly control.
It is also worth to mention a tubular plug flow crystallizer (Neugebauer and Khinast, 2015) . In this platform, the shear rates were generated by contacting the gas bubbles with the liquid flow, and the liquid droplet flow were separated into segments to achieve the optimal transport of crystals along the reactor and a narrow residence time distribution. The temperature can be controlled by multiply stage, which is in same principle of CSTR. However, it is very difficult to control the shear rate in the flow and risk for transferring the crystals in the flow.
Developing a continuous protein crystallisation, from nL and μL for the interest of protein structure determination (Pitchayajittipong et al., 2009) , to meso-scale (mL) or big scale-L were hardly reported. The residence time, yield, crystal quality, purity and size distribution are all important factors in the design of the continuous crystallisation process (Figure 8 ), similar as principles in design of platforms for small organic molecules (Brown et al., 2018) , despite the scales are different (Roberts et al., 2010) (Castro et al., 2016) . The thermodynamics and kinetics are highly determined by supersaturation and share rate, respectively, demonstrated in this work, too. The increase of the supersaturation and share rate can shorten the residence time and, therefore, increase the yield during the same crystallisation time. However, it may lead to poor quality of the crystals, lower purity and wider size distributions, due to high nucleation rate. It also results in high risk to drive the crystallisation solution into a precipitant zone (Chayen and Saridakis, 2008) , in which region the salts crystals, instead of protein crystals, nucleate first. On the other side, decrease in the supersaturation and share rate is better for crystal quality but requires longer residence time, which reduce the yield during the same residence time in manufacturing operation. Extending the residence time in the crystallisation process helps to obtain good quality of crystals, but this decreases the efficiency of the manufacturing. Many thermodynamic and kinetic factors affect each other and need to be tested with the experiments in batch crystallisation before transferring to continuous crystallisation, which would be designed and optimized by design of experiments (Weissman and Anderson, 2014) . In addition, factors, including seeding, surface chemistry and surface topography, porous templates (Barros Groß and Kind, 2017; Delmas et al., 2011 ) (Shah et al., 2015 , which can improve crystallisation of protein, can be tested, optimized and applied in developing continuous crystallisation.
Conclusions
This work demonstrates feasibility of a continuous protein crystallisation under oscillatory flow conditions. In the batch oscillatory flow crystallizer, the higher concentration of lysozyme solution was, the faster nucleation occurred. With same initial concentration of lysozyme, the high frequency and amplitude of the oscillatory condition enhanced the nucleation and crystallization, leading to a reduce in the particle size and increase in the number of the The crystallisation process in continuous oscillatory flow crystallizer was in consistence with the batch oscillatory flow crystallisation process with same oscillatory condition. The process can be further improved by temperature control, enhancing mixing, seeding or adding nano-templates.
The next step is to move the continuous crystallisation of lysozyme to baffled oscillatory flow crystallizer, which was designed by comparing several previous continuous crystallisation platforms, like enforced flow, oscillatory flow, plug flow or mixed suspension mixed product removal crystallizer.
